Back
Ultragenyx Pharmaceutical Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
46
RARE
Ultragenyx Pharmaceutical
Last Price:
52.02
Seasonality Move:
11.62%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.34 | Sell |
| 20-day SMA: | 54.67 | Sell |
| 50-day SMA: | 55.89 | Sell |
| 200-day SMA: | 47.69 | Buy |
| 8-day EMA: | 54.09 | Sell |
| 20-day EMA: | 54.76 | Sell |
| 50-day EMA: | 54.11 | Sell |
| 200-day EMA: | 48.72 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 38.95 | Sell |
| Chaikin Money Flow: | -138218 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.44 - 56.38) | Sell |
| Bollinger Bands (100): | (43.42 - 56.66) | Buy |
Ultragenyx Pharmaceutical Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 52.80 while RARE 8-day simple moving average is 54.34, which is a Sell signal.
- The stock price of RARE is 52.80 while Ultragenyx Pharmaceutical 20-day SMA is 54.67, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 55.89 while RARE share price is 52.80, making it a Sell technically.
- RARE stock price is 52.80 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.69, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $52.80. The Score for RARE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
4.87B
Price in USD:
52.80
Share Volume:
584.77K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
32.83
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 52.80 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 52.80 while RARE 8-day exponential moving average is 54.09, which is a Sell signal.
- The stock price of RARE is 52.80 while Ultragenyx Pharmaceutical 20-day EMA is 54.76, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 54.11 while RARE share price is 52.80, making it a Sell technically.
- RARE stock price is 52.80 and Ultragenyx Pharmaceutical 200-day simple moving average is 48.72, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 38.95, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (53.44 - 56.38), which suggest Ultragenyx Pharmaceutical is a Buy
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (43.42 - 56.66), which suggest Ultragenyx Pharmaceutical is a Buy
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.